GLP-1 pills are coming, and they could revolutionize weight-loss …
Sep 17, 2024 · At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · Eli Lilly’s Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.
Considering GLP-1 medications? What they are and why lifestyle …
The good news is a class of medications called GLP-1 (glucagon-like peptide 1) agonists are emerging as true game changers, helping to control appetite and hunger, and allowing some people to shed pounds they’ve struggled to lose for years.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
On Thursday, ahead of the diabetes conference, Denmark-based biotech firm Zealand Pharma released data that showed a high dose of its experimental weight loss drug petrelintide helped reduce body...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
May 21, 2024 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
A look at the R&D landscape in obesity, led by GLP-1s - Fierce …
Mar 19, 2024 · Viking Therapeutics’ dual GLP-1 and GIP agonist produced weight loss of up to 14.7% after 13 weeks of treatment in data released in February. The results were competitive to the Big Pharma ...
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
Aug 12, 2024 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
New GLP-1 weight loss drug Zepbound approved by FDA: What …
Nov 14, 2023 · Eli Lilly's new obesity medication Zepbound (tirzepatide) recently received FDA approval. Experts explain how the GLP-1 drug works and compares to similar drugs.
How Ozempic, other weight-loss drugs are "changing medicine"
Jan 21, 2024 · GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year.
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.